Incidence, progression, and predictors of left atrial appendage sealing after Watchman FLX device implantation with computed tomographic assessment
Catheterization and Cardiovascular Interventions · 2024
DOI: 10.1002/ccd.31044 ↗At a glance
Journal article in Catheterization and Cardiovascular Interventions, 2024. Written by Sung-Han Yoon and 7 co-authors. Institution: Division of Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA. Major MEDLINE topics: Atrial Appendage, Atrial Fibrillation, Predictive Value of Tests, Cardiac Catheterization. Cited 2 times so far (Crossref); 26 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS.
Abstract (original language)
Background
Limited data exists regarding incidence, progression, and predictors of left atrial appendage (LAA) sealing after transcatheter LAA closure. We aimed to evaluate the incidence, progression, and predictive factors associated with LAA sealing after LAA closure.
Methods
This study includes patients who underwent successful LAA closure with Watchman FLX device and had both pre‐ and postprocedural computed tomography (CT). Postprocedural CT was performed 45 days after LAA closure and used to evaluate residual LAA patency. Patient who had residual LAA patency at 45 days underwent 1‐year follow‐up CT.
Results
A total of 105 patients (mean age: 75.2 ± 9.6 years; 53.3% female) who underwent successful LAA closure with Watchman FLX device and had pre‐ and postprocedural CT at 45 days were included. Residual patency was observed in 35 (33.3%) patients: 21 (20.0%) patients showed complete contrast opacification in LAA (complete LAA patency) while 14 (13.3%) patients showed contrast opacification only in the distal LAA (distal LAA patency). Among patients with residual LAA patency at 45 days, the rate of LAA sealing at 1 year was significantly higher in the distal LAA patency group than in the complete LAA patency group (75.0% vs. 16.7%; p = 0.019). Increased depth oversizing was associated with both distal LAA patency and complete LAA patency.
Conclusion
Postprocedural CT at 45 days detected patent LAA in one‐third of patients after LAA closure. LAA sealing was more frequently observed at 1 year among the distal LAA patency group than the complete LAA patency group.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Cardiology, Harrington Heart and Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA.
- Department of Medicine, Division of Structural Heart Disease, Hackensack University Medical Center, Hackensack, New Jersey, USA.
ORCID profiles: Sung-Han Yoon, Jason Galo, Steven J Filby
Funding
- NHLBI NIH HHS
Cite
APA
Yoon, S. H., Amoah, J. K., Galo, J., Dallan, L. A. P., Arruda, M., Rashid, I., Rajagopalan, S., & Filby, S. J. (2024). Incidence, progression, and predictors of left atrial appendage sealing after Watchman FLX device implantation with computed tomographic assessment. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.31044
Vancouver
Yoon SH, Amoah JK, Galo J, Dallan LAP, Arruda M, Rashid I, et al. Incidence, progression, and predictors of left atrial appendage sealing after Watchman FLX device implantation with computed tomographic assessment. Catheterization and Cardiovascular Interventions. 2024. doi:10.1002/ccd.31044
BibTeX
@article{Yoon2024,
author = {Yoon, Sung-Han and Amoah, Joseph Kofi and Galo, Jason and Dallan, Luis Augusto Palma and Arruda, Mauricio and Rashid, Imran and Rajagopalan, Sanjay and Filby, Steven J},
title = {Incidence, progression, and predictors of left atrial appendage sealing after Watchman FLX device implantation with computed tomographic assessment},
journal = {Catheterization and Cardiovascular Interventions},
year = {2024},
doi = {10.1002/ccd.31044}
}
EUVIMED